Steven B Kleiboeker
Overview
Explore the profile of Steven B Kleiboeker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walder T, Odegard E, Meeds H, Kleiboeker S, Ziady A, Sabulski A, et al.
Microbiol Resour Announc
. 2024 Sep;
13(11):e0067624.
PMID: 39345196
BK polyomavirus (BKPyV) is associated with disease in transplant patients. BKPyV genomic diversity is thought to contribute to functional differences in virulence factors. Here, we present the near full-length BKPyV...
2.
Servais A, McMullen J, Bowen R, Kleiboeker S, Ulloa I, Duncan K, et al.
Transpl Infect Dis
. 2024 May;
26(4):e14291.
PMID: 38708965
Background: Valganciclovir prophylaxis against cytomegalovirus (CMV) is recommended for solid organ transplant recipients, but is associated with drawbacks, including expense and leukopenia. Our center adopted a strategy of serial assessment...
3.
Chokshi S, Odegard E, Meeds H, Kleiboeker S, Ziady A, Sabulski A, et al.
Microbiol Resour Announc
. 2024 Apr;
13(6):e0000524.
PMID: 38647278
The role of viral diversity in the pathogenesis of BK polyomavirus (BKPyV)-associated disease is poorly understood. Here, we report near full-length BKPyV genome sequences from two allogeneic hematopoietic cell transplant...
4.
Odegard E, Meeds H, Kleiboeker S, Ziady A, Sabulski A, Jodele S, et al.
J Infect Dis
. 2023 May;
228(9):1208-1218.
PMID: 37165301
BK polyomavirus (BKPyV) infection is common after hematopoietic stem cell transplantation (HSCT) and is associated with the development of hemorrhagic cystitis (HC). The role that BKPyV plays in the pathogenesis...
5.
Kleiboeker S
Antiviral Res
. 2023 May;
215:105623.
PMID: 37150409
Cytomegalovirus (CMV) is a significant human pathogen, especially for immunocompromised patients, often treated with one or more antiviral drugs. Although the prevalence of resistance is low, the impact of drug...
6.
Odegard E, Meeds H, Kleiboeker S, Ziady A, Sabulski A, Jodele S, et al.
Microbiol Resour Announc
. 2022 Jan;
11(1):e0105321.
PMID: 34989611
Symptomatic BK polyomavirus (BKPyV) infections are common and relevant in immunocompromised patients. Here, we present full-length BKPyV genomes from samples from patients who received hematopoietic cell transplants in the United...
7.
Odegard E, Meeds H, Kleiboeker S, Ziady A, Sabulski A, Jodele S, et al.
J Virol Methods
. 2021 Oct;
299:114319.
PMID: 34627948
BK polyomavirus (BKPyV) is a ubiquitous pathogen that typically results in asymptomatic infection. However, in immunocompromised individuals, BKPyV viral shedding in the urine can reach 10 copies per mL. These...
8.
Bleichner L, Bleicher V, Gohring N, Kleiboeker S
J AOAC Int
. 2021 Apr;
104(4):872-888.
PMID: 33848353
Background: The Eurofins GeneScan Technologies' VIRSeek SARS-CoV-2 Mplex kit is a RT (reverse transcription) real-time polymerase chain reaction (RT-qPCR) assay for the detection of two targets on the N-gene (nucleocapsid)...
9.
Odegard E, Meeds H, Kleiboeker S, Ziady A, Sabulski A, Jodele S, et al.
Microbiol Resour Announc
. 2021 Jan;
10(2).
PMID: 33446585
BK polyomavirus (BKPyV) infection can lead to nephropathy and hemorrhagic cystitis (HC). We evaluated BKPyV genotypes in two individuals after hematopoietic cell transplant (HCT). The first case developed HC and...
10.
Dulipsingh L, Ibrahim D, Schaefer E, Crowell R, Diffenderfer M, Williams K, et al.
Transfus Apher Sci
. 2020 Sep;
59(6):102922.
PMID: 32883593
SARS-CoV-2 has infected millions worldwide. The virus is novel, and currently there is no approved treatment. Convalescent plasma may offer a treatment option. We evaluated trends of IgM/IgG antibodies/plasma viral...